These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35189111)

  • 1. Multi-institutional Analysis of 505 Patients With Coronavirus Disease-2019 Supported With Extracorporeal Membrane Oxygenation: Predictors of Survival.
    Hall CA; Jacobs JP; Stammers AH; St Louis JD; Hayanga JWA; Firstenberg MS; Mongero LB; Tesdahl EA; Rajagopal K; Cheema FH; Patel K; Coley T; Sestokas AK; Slepian MJ; Badhwar V
    Ann Thorac Surg; 2022 Jul; 114(1):61-68. PubMed ID: 35189111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in survival in patients with Coronavirus Disease 2019 supported with extracorporeal membrane oxygenation: A multi-institutional analysis of 594 consecutive patients with Coronavirus Disease 2019 supported with extracorporeal membrane oxygenation at 49 hospitals within 21 states.
    Jacobs JP; Stammers AH; St Louis JD; Tesdahl EA; Hayanga JWA; Morris RJ; Lee RC; Sestokas AK; Badhwar V; Weinstein S
    J Thorac Cardiovasc Surg; 2023 May; 165(5):1837-1848. PubMed ID: 36116956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-institutional Analysis of 200 COVID-19 Patients Treated With Extracorporeal Membrane Oxygenation: Outcomes and Trends.
    Jacobs JP; Stammers AH; St Louis JD; Hayanga JWA; Firstenberg MS; Mongero LB; Tesdahl EA; Rajagopal K; Cheema FH; Patel K; Coley T; Sestokas AK; Slepian MJ; Badhwar V
    Ann Thorac Surg; 2022 May; 113(5):1452-1460. PubMed ID: 34242641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Extracorporeal Membrane Oxygenation in COVID-19 Patients with Severe Cardiorespiratory Failure: The Influence of Obesity on Outcomes.
    Mongero LB; Stammers AH; Tesdahl EA; Petersen C; Patel K; Jacobs JP
    J Extra Corpor Technol; 2021 Dec; 53(4):293-298. PubMed ID: 34992320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-institutional Analysis of 100 Consecutive Patients with COVID-19 and Severe Pulmonary Compromise Treated with Extracorporeal Membrane Oxygenation: Outcomes and Trends Over Time.
    Jacobs JP; Stammers AH; Louis JS; Hayanga JWA; Firstenberg MS; Mongero LB; Tesdahl EA; Rajagopal K; Cheema FH; Patel K; Esseghir F; Coley T; Sestokas AK; Slepian MJ; Badhwar V
    ASAIO J; 2021 May; 67(5):496-502. PubMed ID: 33902100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors of Mortality for Patients Receiving Venovenous Extracorporeal Membrane Oxygenation for COVID-19 Acute Respiratory Distress Syndrome.
    Bergman ZR; Wothe JK; Alwan FS; Lofrano AE; Tointon KM; Doucette M; Bohman JK; Saavedra-Romero R; Prekker ME; Lusczek ER; Beilman G; Brunsvold ME
    Surg Infect (Larchmt); 2021 Dec; 22(10):1086-1092. PubMed ID: 34494893
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics and Outcomes of COVID-19 Patients Supported by Venoarterial or Veno-Arterial-Venous Extracorporeal Membrane Oxygenation.
    Haroun MW; Patel SR; Sims DB; Jorde UP; Goldstein DJ; Saeed O
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2935-2941. PubMed ID: 35249832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venovenous extracorporeal membrane oxygenation for patients with refractory coronavirus disease 2019 (COVID-19): Multicenter experience of referral hospitals in a large health care system.
    Shih E; DiMaio JM; Squiers JJ; Banwait JK; Meyer DM; George TJ; Schwartz GS;
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):1071-1079.e3. PubMed ID: 33419553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study.
    Diaz RA; Graf J; Zambrano JM; Ruiz C; Espinoza JA; Bravo SI; Salazar PA; Bahamondes JC; Castillo LB; Gajardo AIJ; Kursbaum A; Ferreira LL; Valenzuela J; Castillo RE; Pérez-Araos RA; Bravo M; Aquevedo AF; González MG; Pereira R; Ortega L; Santis C; Fernández PA; Cortés V; Cornejo RA
    Am J Respir Crit Care Med; 2021 Jul; 204(1):34-43. PubMed ID: 33823118
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant Use During Extracorporeal Membrane Oxygenation Using Heparin and Direct Thrombin Inhibitors in COVID-19 and ARDS Patients.
    Stammers AH; Tesdahl EA; Barletti S; Mongero L; Patel K; Mosca M; Sestokas A; Firstenberg MS; Jacobs JP
    J Extra Corpor Technol; 2022 Sep; 54(3):223-234. PubMed ID: 36742213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study.
    Lebreton G; Schmidt M; Ponnaiah M; Folliguet T; Para M; Guihaire J; Lansac E; Sage E; Cholley B; Mégarbane B; Cronier P; Zarka J; Da Silva D; Besset S; Morichau-Beauchant T; Lacombat I; Mongardon N; Richard C; Duranteau J; Cerf C; Saiydoun G; Sonneville R; Chiche JD; Nataf P; Longrois D; Combes A; Leprince P;
    Lancet Respir Med; 2021 Aug; 9(8):851-862. PubMed ID: 33887246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris.
    Schmidt M; Langouet E; Hajage D; James SA; Chommeloux J; Bréchot N; Barhoum P; Lefèvre L; Troger A; de Chambrun MP; Hékimian G; Luyt CE; Dres M; Constantin JM; Fartoukh M; Leprince P; Lebreton G; Combes A;
    Crit Care; 2021 Oct; 25(1):355. PubMed ID: 34627350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study.
    Lorusso R; De Piero ME; Mariani S; Di Mauro M; Folliguet T; Taccone FS; Camporota L; Swol J; Wiedemann D; Belliato M; Broman LM; Vuylsteke A; Kassif Y; Scandroglio AM; Fanelli V; Gaudard P; Ledot S; Barker J; Boeken U; Maier S; Kersten A; Meyns B; Pozzi M; Pedersen FM; Schellongowski P; Kirali K; Barrett N; Riera J; Mueller T; Belohlavek J;
    Lancet Respir Med; 2023 Feb; 11(2):151-162. PubMed ID: 36402148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure.
    Pettignano R; Fortenberry JD; Heard ML; Labuz MD; Kesser KC; Tanner AJ; Wagoner SF; Heggen J
    Pediatr Crit Care Med; 2003 Jul; 4(3):291-8. PubMed ID: 12831409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal Membrane Oxygenation Support in Severe COVID-19.
    Kon ZN; Smith DE; Chang SH; Goldenberg RM; Angel LF; Carillo JA; Geraci TC; Cerfolio RJ; Montgomery RA; Moazami N; Galloway AC
    Ann Thorac Surg; 2021 Feb; 111(2):537-543. PubMed ID: 32687823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early posthospitalization recovery after extracorporeal membrane oxygenation in survivors of COVID-19.
    Taylor LJ; Jolley SE; Ramani C; Mayer KP; Etchill EW; Mart MF; Fakhri S; Peterson S; Colborn K; Sevin CM; Kadl A; Enfield K; Whitman GJR; Zwischenberger JB; Rove JY;
    J Thorac Cardiovasc Surg; 2023 Sep; 166(3):842-851.e1. PubMed ID: 35431034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early mobilization in coronavirus-19 patients treated with extracorporeal membrane oxygenation.
    George TJ; Sheasby J; Taylor JE; Vaquera KA; Curry MW; Harness-Brumley CL; Myers DP; Erwin GE; Lilly JC; Michael DiMaio J
    J Card Surg; 2022 Dec; 37(12):4536-4542. PubMed ID: 36316816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Demographics and Extracorporeal Membranous Oxygenation (ECMO)-Related Complications Associated With Survival to Discharge or 30-Day Survival in Adult Patients Receiving Venoarterial (VA) and Venovenous (VV) ECMO in a Quaternary Care Urban Center.
    Kaushal M; Schwartz J; Gupta N; Im J; Leff J; Jakobleff WA; Leyvi G
    J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):910-917. PubMed ID: 30245110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study.
    Fang J; Li R; Chen Y; Qin JJ; Hu M; Huang CL; Cheng L; He Y; Li Y; Zhou Q; Zhou DX; Huang F; Lei F; Yang B; Chen J; Deng HP; Yuan YF; Xia JH; Wan S; Li HL; Wei X
    Curr Med Sci; 2021 Feb; 41(1):1-13. PubMed ID: 33582899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for the Mortality of Patients With Coronavirus Disease 2019 Requiring Extracorporeal Membrane Oxygenation in a Non-Centralized Setting: A Nationwide Study.
    Kim TW; Kim WY; Park S; Lee SH; Park O; Kim T; Yeo HJ; Jang JH; Cho WH; Huh JW; Lee SM; Chung CR; Lee J; Kim JS; Lim SY; Baek AR; Yoo JW; Kim HC; Choi EY; Park C; Kim TO; Moon DS; Lee SI; Moon JY; Kwon SJ; Seong GM; Jung WJ; Baek MS;
    J Korean Med Sci; 2024 Mar; 39(8):e75. PubMed ID: 38442718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.